BioNTech SE ADR

2026. aug. 24. 23:26 UTC

Biontech SE shares are lower in after-market trading with no specific news identified. Broader market volatility is influenced by geopolitical developments and U.S. sanctions on Iran.

2026. aug. 21. 20:01 UTC

BioNTech SE shares are higher as the company prepares to present new lung cancer treatment data at the IASLC conference in 2026.

2026. aug. 20. 23:16 UTC

BioNTech SE shares are lower in after-market trading as it announces new clinical data for lung cancer treatment at the IASLC conference in 2026.

2026. aug. 19. 23:41 UTC

BioNTech SE is trading lower in after-market hours amid a decline in the Biotechnology sub-sector and concerns over neoantigen vaccines and capital strategies.

2026. aug. 18. 21:01 UTC

BioNTech SE shares are trading lower in after-market hours, amid cautious sentiment linked to fluctuations in sovereign bond yields.

2026. aug. 17. 19:56 UTC

BioNTech SE shares are lower today, reflecting broader market trends amid rising crude oil prices and inflationary pressures. The stock peaked earlier in the session.

2026. aug. 14. 19:26 UTC

BioNTech SE shares are higher today, continuing an upward trend since Thursday. This movement occurs despite concerns over declining U.S. retail sales data.

2026. aug. 13. 19:21 UTC

BioNTech SE shares are lower as analysts adjust price targets following a significant second-quarter revenue decline and a net loss of €820.8 million.

2026. aug. 12. 19:26 UTC

BioNTech SE's shares are higher today, supported by a significant rise in Moderna Inc. amid optimistic market sentiment following recent inflation data.

2026. aug. 11. 20:06 UTC

BioNTech SE shares are near unchanged amid a flat market performance. The stock remains above its 20-day moving average and near the upper end of its one-month range.

2026. aug. 10. 21:01 UTC

BioNTech SE shares are higher in after-market trading, showing stability despite broader market conditions and weaker-than-expected job growth data.

2026. aug. 7. 19:56 UTC

BioNTech SE is trading higher, likely influenced by Moderna's significant gains. The stock remains above its 20-day moving average despite recent revenue declines.

2026. aug. 6. 19:51 UTC

BioNTech SE shares are lower amid negative sentiment in the Biotechnology sector, following a revenue decline and CEO transition announcement.

2026. aug. 5. 19:32 UTC

BioNTech SE shares are higher today after Citigroup maintained its Buy rating, lowering its price target to $125 while Evercore ISI kept its Outperform rating at $130.

2026. aug. 4. 20:03 UTC

BioNTech SE reported a widened second-quarter loss and lowered 2026 revenue guidance, contributing to shares trading lower since Monday's close.

2026. aug. 3. 21:01 UTC

BioNTech SE shares are lower in after-market hours, showing little movement despite a broader market rally and investor optimism from lower oil prices.

2026. júl. 31. 19:16 UTC

BioNTech SE shares are lower today, pressured by broader market sentiment and a decline in Moderna Inc. The stock remains below its 20-day moving average.

2026. júl. 30. 21:01 UTC

BioNTech SE shares are trading lower in after-market hours, reversing earlier gains and reflecting notable volatility without any specific news to explain the movement.

2026. júl. 29. 19:55 UTC

BioNTech SE shares are advancing during Wednesday's session, reaching a session high earlier today before pulling back slightly. No specific news was identified.

2026. júl. 28. 19:16 UTC

BioNTech SE shares are advancing today, rebounding from earlier lows. The stock's resilience contrasts with declines in the Nikkei 225 Index.

2026. júl. 27. 19:06 UTC

BioNTech SE shares are higher today amid positive market sentiment, reaching a peak earlier. No specific news has been identified to explain the movement.

2026. júl. 24. 19:06 UTC

BioNTech SE shares are lower today, continuing a decline amid broader market pressure and a significant drop in crude oil prices.

2026. júl. 22. 18:06 UTC

BioNTech SE shares are lower today, reflecting broader market caution amid rising crude oil prices and geopolitical tensions ahead of major technology earnings reports.

2026. júl. 21. 14:41 UTC

BioNTech SE is rising amid positive market sentiment and plans to report second-quarter 2026 results on August 4, 2026. The Nasdaq 100 Index is also up.

2026. júl. 20. 19:06 UTC

BioNTech SE shares are higher today, supported by a positive analyst outlook and an average recommendation of "Moderate Buy" from nineteen brokerage firms.